Special report: The Fierce 50 of 2024

drug access

BMS
Pharma

BMS rolls out 10-year drug access plan in lower-income countries

In its quest to reach more than 200,000 patients in low- and middle-income countries, BMS is embarking on a 10-year access effort.
Fraiser Kansteiner May 22, 2024 10:20am
GSK

GSK plays defense on call to pull popular children's asthma med

May 3, 2024 10:19am
drug prices biologics drug costs IRA money cash payment co-pay

GLP-1s still unavailable in lower-income countries: MSF

Mar 28, 2024 8:00am
Viatris campaign on Nasdaq tower in Times Square

Viatris launches brand campaign on Nasdaq tower in Times Square

Nov 16, 2023 10:53am
topic report
Fierce 50 Social Impact Category Honorees

Fierce 50: Social Impact honorees

Oct 2, 2023 4:00am
topic report
Fierce 50 Health Equity Category Honorees

Fierce 50: Health Equity honorees

Oct 2, 2023 4:00am